Thanks @UABAlumni for having me on #GreenAndTold!
We talked mice as crash test dummies, 96% cancer clinical trial failure rate, and the one job every biotech CEO actually has: push doom off by one day!
@CoeCollege @UABNews @UABEngineering @UABHeersink @CerFlux #CrushCancer
🎙️Dr. Karim I. Budhwani
🏫@uabheersink @uabengineering
💼CEO of CerFlux
One day - that's all it takes. Hear Dr. Karim Budhwani's story now.
🔗alumni.uab.edu/greenandtold
Thanks @UABAlumni for having me on #GreenAndTold! We talked mice as crash test dummies, 96% cancer clinical trial failure rate, and the one job every biotech CEO actually has: push doom off by one day!
@CoeCollege | @UABNews | @UABEngineering | @AKUGlobal | @CerFlux #CrushCancer
🎙️Dr. Karim I. Budhwani
🏫@uabheersink @uabengineering
💼CEO of CerFlux
One day - that's all it takes. Hear Dr. Karim Budhwani's story now.
🔗alumni.uab.edu/greenandtold
Dr. Karim I. Budhwani retweeted
💡New #review highlights how 3D bioprinted tumor models can better capture tumor microenvironment complexity and improve preclinical evaluation of pan-RAS inhibitors like ADT-007.
✍by Daniela D. De Nobrega et al. @CerFlux @CeoScientist
📌Full paper: mdpi.com/2072-6694/17/18/295…
Dr. Karim I. Budhwani retweeted
A group of middle school students from the Alabama School of Fine Arts (ASFA) is receiving national recognition for work rarely associated with students their age: using artificial intelligence to study the effectiveness of cancer treatments.
The ASFA students have been awarded a $1,000 Promising STEM Innovation Award in the 2025–2026 Samsung Solve for Tomorrow national competition for a cancer research project developed in collaboration with Birmingham-based biotech company CerFlux.
Selected from thousands of student submissions nationwide, the ASFA middle school team was recognized for a project that applies AI and advanced imaging tools to better understand how tumor structure influences whether cancer treatments succeed or fail.
While cancer research is typically the domain of universities and professional laboratories, these students are working with real-world scientific methods—analyzing data, interpreting digital pathology images and using artificial intelligence to examine the tumor microenvironment.
Read the full piece here: yellowhammernews.com/alabama…
#Alabama #news #ASFA #AI #cancer #treatment #STEMaward
Hats off to amazing @Delta gate agents at BHM gate A4! Thank you for making travel easier and BHM the center of the universe!
Dr. Karim I. Budhwani retweeted
In a powerful moment of history, African American Senator Cory Booker has broken Strom Thurmond’s record for the longest speech on the Senate floor—a record originally set in opposition to the Civil Rights Act. Now, in a striking reversal of purpose, Booker’s protest targets Donald Trump.
April 1 may go down as a turning point—the beginning of the end for Trump. The tides are shifting.
Dr. Karim I. Budhwani retweeted
Henna Budhwani, Ph.D., MPH from the College of Nursing, (@fsunursing), has been named the inaugural recipient of the Michael and Paula Read Phelan Professorship in Obstetrical Nursing at the FSU College of Nursing. 👶🩺🌟
#FSU #FSUFaculty
Dr. Karim I. Budhwani retweeted
Dr. Rachael Guenter from UAB is at the forefront of developing new theranostic agents and advancing detection methods for neuroendocrine tumors. Her work reflects a commitment to improving outcomes for patients facing advanced disease.
#EarlyCareerSpotlight #NETResearch #NANETS
Dr. Karim I. Budhwani retweeted
Dr. Henna Budhwani has been named the inaugural recipient of the Michael and Paula Read Phelan Professorship in Obstetrical Nursing! She will lead maternal health research and initiatives, focusing on supporting women in under-resourced communities–bit.ly/3YClEhg.
#FSU
Dr. Karim I. Budhwani retweeted
The Avengers have assembled to save democracy and elect Kamala Harris as our next president.
Dr. Karim I. Budhwani retweeted
Has the U.S. economy, historically, been better under Republican presidents or Democratic presidents?
A Republican financial analyst decided to find out.
His name? Bart Starr, Jr. (Yes, the son of THAT Bart Starr.)
The answer may surprise you.🧵
Dr. Karim I. Budhwani retweeted
CahabaQue is today! 🐷
Don't miss out - see you all at 12 PM!
Get your tickets at the gate!
Dr. Karim I. Budhwani retweeted
ALT The text "always ask employers why the position is open" with a picture of JD Vance and Mike Pence
My latest perspective published in @BrJCancer on harnessing #AI in #oncology while mitigating risks : A novel "scienthetic method" tracing an arc from #Aristotle to AI and the future of #medicine that calls for integrating machine intelligence with human wisdom. Enjoy!
ALT Image generated by Microsoft Bing Image Creator depicting (from left to right) Plato, Aristotle, Socrates, (presumably a younger me?), and AI discussing the evolution of the scientific method into the scienthetic method.
Dr. Karim I. Budhwani retweeted
Drs. Henna Budhwani and Lisa Hightow-Weidman from @FloridaState are working to address COVID-19 vaccine hesitancy among Black young adults in the southern United States. Learn about their innovative intervention: bit.ly/3M6m2yL #NIMHDInsights @medsociology @drweidman
ALT Graphic promoting an NIMHD Insights Blog titled, Breaking Barriers: Empowering Black Young Adults to Embrace COVID-19 Vaccination. Features NIMHD Logo and headshots of Drs. Henna Budhwani and Lisa Hightow-Weidman
Dr. Karim I. Budhwani retweeted
Shoutout to Professor Henna Budhwani! The five-year Cystic Fibrosis Foundation-funded study, Research Expansion to Advance the CFTherapeutic Pipeline for People without Modulators (REACH), on which Dr. Budhwani is a co-investigator, has been awarded an impressive $1.6 million!
Dr. Karim I. Budhwani retweeted
Excited to share our collaborative work out today in Nature Reviews Methods Primers:
Spatial Multiplexing and Omics
rdcu.be/dPEM0